Francesca Gallia

1.3k total citations
26 papers, 713 citations indexed

About

Francesca Gallia is a scholar working on Neurology, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Francesca Gallia has authored 26 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Neurology, 15 papers in Cellular and Molecular Neuroscience and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Francesca Gallia's work include Peripheral Neuropathies and Disorders (23 papers), Hereditary Neurological Disorders (14 papers) and Peripheral Nerve Disorders (6 papers). Francesca Gallia is often cited by papers focused on Peripheral Neuropathies and Disorders (23 papers), Hereditary Neurological Disorders (14 papers) and Peripheral Nerve Disorders (6 papers). Francesca Gallia collaborates with scholars based in Italy, United States and Spain. Francesca Gallia's co-authors include Eduardo Nobile‐Orazio, Fabrizia Terenghi, Claudia Giannotta, Paolo Messina, Andrea Nozza, Dario Cocito, Raffaella Fazio, Guido Cavaletti, Giovanni Antonini and Antonino Uncini and has published in prestigious journals such as Brain, Neurology and Scientific Reports.

In The Last Decade

Francesca Gallia

25 papers receiving 673 citations

Peers

Francesca Gallia
Francesca Gallia
Citations per year, relative to Francesca Gallia Francesca Gallia (= 1×) peers Yuki Fukami

Countries citing papers authored by Francesca Gallia

Since Specialization
Citations

This map shows the geographic impact of Francesca Gallia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Gallia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Gallia more than expected).

Fields of papers citing papers by Francesca Gallia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Gallia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Gallia. The network helps show where Francesca Gallia may publish in the future.

Co-authorship network of co-authors of Francesca Gallia

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Gallia. A scholar is included among the top collaborators of Francesca Gallia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Gallia. Francesca Gallia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nobile‐Orazio, Eduardo, Dario Cocito, Raffaella Fazio, et al.. (2024). Rituximab versus placebo for chronic inflammatory demyelinating polyradiculoneuropathy: a randomized trial. Brain. 148(4). 1112–1121. 7 indexed citations
2.
Doneddu, Pietro Emiliano, Dario Cocito, Raffaella Fazio, et al.. (2024). Prospective open-label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies. Journal of Neurology Neurosurgery & Psychiatry. 95(9). 838–844. 9 indexed citations
3.
Cardamone, Giulia, Elvezia Maria Paraboschi, Giulia Soldà, et al.. (2022). The circular RNA landscape in multiple sclerosis: Disease-specific associated variants and exon methylation shape circular RNA expression profile. Multiple Sclerosis and Related Disorders. 69. 104426–104426. 13 indexed citations
4.
Riva, Nilo, Francesco Gentile, Federica Cerri, et al.. (2021). Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis. Brain. 145(1). 276–284. 29 indexed citations
5.
Liberatore, Giuseppe, Claudia Giannotta, Emanuela Morenghi, et al.. (2020). Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy. Journal of Neuroimmunology. 345. 577288–577288. 23 indexed citations
6.
Perić, Stojan, Pietro Emiliano Doneddu, Francesca Gallia, et al.. (2018). Corticosteroids in chronic inflammatory demyelinating polyneuropathy. Journal of Neurology. 265(9). 2052–2059. 34 indexed citations
7.
Bianco, Mariangela, Fabrizia Terenghi, Francesca Gallia, et al.. (2018). Clinical, electrophysiological and VEGF 2-year response after lenalidomide or stem cell transplantation in patients with POEMS syndrome. Journal of Neurology Neurosurgery & Psychiatry. 90(3). 367–368. 4 indexed citations
8.
Nozza, Andrea, Fabrizia Terenghi, Francesca Gallia, et al.. (2017). Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open‐label trial. British Journal of Haematology. 179(5). 748–755. 51 indexed citations
9.
Nobile‐Orazio, Eduardo, Dario Cocito, Chiara Briani, et al.. (2017). High-dose Ig VENA is well tolerated and efficacious in patients with multifocal motor neuropathy. Neurological Sciences. 38(5). 899–902. 1 indexed citations
10.
Gallia, Francesca, Claudia Balducci, & Eduardo Nobile‐Orazio. (2016). Efficacy and tolerability of different brands of intravenous immunoglobulin in the maintenance treatment of chronic immune‐mediated neuropathies. Journal of the Peripheral Nervous System. 21(2). 82–84. 7 indexed citations
11.
Riva, Nilo, Ferdinando Clarelli, Teuta Domi, et al.. (2016). Unraveling gene expression profiles in peripheral motor nerve from amyotrophic lateral sclerosis patients: insights into pathogenesis. Scientific Reports. 6(1). 39297–39297. 20 indexed citations
12.
Nobile‐Orazio, Eduardo & Francesca Gallia. (2015). Update on the treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Current Opinion in Neurology. 28(5). 480–485. 8 indexed citations
13.
Giannotta, Claudia, et al.. (2015). Anti‐sulfatide IgM antibodies in peripheral neuropathy: to test or not to test?. European Journal of Neurology. 22(5). 879–882. 18 indexed citations
14.
Nobile‐Orazio, Eduardo, Dario Cocito, S. Jann, et al.. (2014). Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP. Journal of Neurology Neurosurgery & Psychiatry. 86(7). 729–734. 65 indexed citations
15.
Nobile‐Orazio, Eduardo, Dario Cocito, S. Jann, et al.. (2013). Frequency and time to relapse after therapy discontinuation in CIDP patients treated for six months with IVIg or IV Methylprednisolone (IMC follow-up study). Journal of the Peripheral Nervous System. 18. 80–81. 4 indexed citations
16.
Nobile‐Orazio, Eduardo, Claudia Giannotta, L. Musset, et al.. (2013). Sensitivity and predictive value of anti-GM1/galactocerebroside IgM antibodies in multifocal motor neuropathy. Journal of Neurology Neurosurgery & Psychiatry. 85(7). 754–758. 54 indexed citations
17.
Nobile‐Orazio, Eduardo, Dario Cocito, S. Jann, et al.. (2012). Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. The Lancet Neurology. 11(6). 493–502. 152 indexed citations
18.
Riva, Nilo, Francesca Gallia, Sandro Iannaccone, et al.. (2011). Chronic motor axonal neuropathy. Journal of the Peripheral Nervous System. 16(4). 341–346. 10 indexed citations
19.
Nobile‐Orazio, Eduardo, et al.. (2010). Chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: treatment update. Current Opinion in Neurology. 23(5). 519–523. 10 indexed citations
20.
Nobile‐Orazio, Eduardo, Francesca Gallia, Fabrizia Terenghi, et al.. (2007). How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?. Journal of the Neurological Sciences. 266(1-2). 156–163. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026